Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Energy Metabolism | 44 | 2023 | 992 | 3.940 |
Why?
|
Body Composition | 42 | 2022 | 595 | 3.330 |
Why?
|
Water | 15 | 2022 | 361 | 3.100 |
Why?
|
Deuterium | 18 | 2022 | 111 | 2.430 |
Why?
|
Isoflavones | 7 | 2013 | 72 | 2.290 |
Why?
|
Adipose Tissue | 18 | 2022 | 769 | 2.200 |
Why?
|
Oxygen Isotopes | 15 | 2022 | 36 | 1.990 |
Why?
|
Self Concept | 4 | 2016 | 211 | 1.630 |
Why?
|
Obesity | 17 | 2023 | 2884 | 1.460 |
Why?
|
Health Expenditures | 2 | 2023 | 211 | 1.450 |
Why?
|
Body Water | 21 | 2018 | 132 | 1.440 |
Why?
|
Exercise | 14 | 2023 | 1183 | 1.430 |
Why?
|
Body Weight | 20 | 2021 | 1293 | 1.370 |
Why?
|
Body Mass Index | 20 | 2018 | 2203 | 1.230 |
Why?
|
Menopause | 3 | 2013 | 159 | 1.220 |
Why?
|
beta-Glucans | 3 | 2013 | 34 | 1.180 |
Why?
|
Dietary Supplements | 7 | 2021 | 558 | 1.100 |
Why?
|
Hepatitis C, Chronic | 2 | 2021 | 451 | 1.090 |
Why?
|
Energy Intake | 17 | 2021 | 515 | 1.050 |
Why?
|
Minority Groups | 5 | 2017 | 322 | 0.950 |
Why?
|
Postmenopause | 3 | 2010 | 378 | 0.950 |
Why?
|
Health Care Costs | 4 | 2023 | 674 | 0.920 |
Why?
|
Weight Reduction Programs | 3 | 2016 | 78 | 0.920 |
Why?
|
Weight Loss | 7 | 2018 | 627 | 0.870 |
Why?
|
Camping | 3 | 2016 | 15 | 0.840 |
Why?
|
Diet | 8 | 2019 | 1440 | 0.780 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 941 | 0.750 |
Why?
|
Absorptiometry, Photon | 8 | 2022 | 239 | 0.750 |
Why?
|
Plant Extracts | 2 | 2012 | 215 | 0.700 |
Why?
|
Bone Density | 6 | 2009 | 476 | 0.690 |
Why?
|
Deuterium Oxide | 5 | 2015 | 20 | 0.690 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2018 | 10 | 0.670 |
Why?
|
Quality of Life | 3 | 2023 | 4532 | 0.670 |
Why?
|
Basal Metabolism | 11 | 2023 | 88 | 0.660 |
Why?
|
Indicator Dilution Techniques | 4 | 2022 | 22 | 0.650 |
Why?
|
Dementia | 1 | 2023 | 453 | 0.630 |
Why?
|
Mass Spectrometry | 8 | 2015 | 702 | 0.630 |
Why?
|
Quality-Adjusted Life Years | 2 | 2023 | 226 | 0.630 |
Why?
|
Diet, Carbohydrate-Restricted | 4 | 2020 | 20 | 0.630 |
Why?
|
Isotope Labeling | 8 | 2022 | 142 | 0.620 |
Why?
|
Hydrogen | 6 | 2012 | 58 | 0.610 |
Why?
|
Milk, Human | 7 | 2015 | 277 | 0.590 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2015 | 182 | 0.580 |
Why?
|
Female | 100 | 2023 | 141928 | 0.570 |
Why?
|
Ontario | 5 | 2023 | 98 | 0.570 |
Why?
|
Breast Feeding | 6 | 2019 | 239 | 0.550 |
Why?
|
Anthropometry | 5 | 2015 | 269 | 0.540 |
Why?
|
Community Health Services | 2 | 2016 | 126 | 0.530 |
Why?
|
Urinalysis | 1 | 2015 | 84 | 0.530 |
Why?
|
Body Fat Distribution | 1 | 2015 | 29 | 0.520 |
Why?
|
Diet, Reducing | 2 | 2020 | 87 | 0.520 |
Why?
|
Overweight | 6 | 2018 | 484 | 0.520 |
Why?
|
Cross-Sectional Studies | 14 | 2023 | 4314 | 0.520 |
Why?
|
Kidney Failure, Chronic | 3 | 2013 | 960 | 0.520 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2021 | 2027 | 0.510 |
Why?
|
Cost of Illness | 2 | 2021 | 498 | 0.510 |
Why?
|
Humans | 131 | 2023 | 261506 | 0.500 |
Why?
|
Sleep | 3 | 2016 | 413 | 0.500 |
Why?
|
Male | 73 | 2023 | 123000 | 0.490 |
Why?
|
Osteoporosis, Postmenopausal | 2 | 2011 | 37 | 0.480 |
Why?
|
Health Promotion | 2 | 2016 | 502 | 0.470 |
Why?
|
Young Adult | 23 | 2023 | 21445 | 0.460 |
Why?
|
Adult | 64 | 2023 | 77950 | 0.450 |
Why?
|
Nephrotic Syndrome | 1 | 2013 | 57 | 0.450 |
Why?
|
Adolescent | 30 | 2023 | 31252 | 0.440 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2012 | 101 | 0.430 |
Why?
|
Child | 28 | 2022 | 29154 | 0.420 |
Why?
|
Nutritional Status | 2 | 2015 | 337 | 0.400 |
Why?
|
Phytoestrogens | 2 | 2010 | 26 | 0.400 |
Why?
|
Hepatitis B, Chronic | 1 | 2013 | 137 | 0.400 |
Why?
|
Peritoneal Dialysis | 2 | 2012 | 125 | 0.390 |
Why?
|
Blood Urea Nitrogen | 1 | 2010 | 95 | 0.390 |
Why?
|
Emigrants and Immigrants | 1 | 2013 | 147 | 0.390 |
Why?
|
Nutritional Requirements | 7 | 2018 | 185 | 0.380 |
Why?
|
Antiviral Agents | 2 | 2021 | 1230 | 0.380 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4557 | 0.370 |
Why?
|
Reproducibility of Results | 13 | 2017 | 6009 | 0.370 |
Why?
|
Child Nutritional Physiological Phenomena | 3 | 2016 | 174 | 0.360 |
Why?
|
Child, Preschool | 19 | 2022 | 16273 | 0.360 |
Why?
|
Blood Pressure | 3 | 2017 | 1467 | 0.360 |
Why?
|
Liver Transplantation | 2 | 2021 | 1112 | 0.350 |
Why?
|
Middle Aged | 36 | 2022 | 86204 | 0.350 |
Why?
|
Vitamin B Complex | 1 | 2009 | 51 | 0.340 |
Why?
|
Behavior Therapy | 1 | 2012 | 298 | 0.340 |
Why?
|
Adiposity | 3 | 2021 | 237 | 0.330 |
Why?
|
Infant | 22 | 2022 | 13310 | 0.320 |
Why?
|
Nitric Oxide | 1 | 2012 | 644 | 0.320 |
Why?
|
Pregnancy, Twin | 2 | 2018 | 118 | 0.310 |
Why?
|
Infant, Newborn | 25 | 2022 | 8223 | 0.310 |
Why?
|
Models, Biological | 13 | 2014 | 3254 | 0.310 |
Why?
|
Program Evaluation | 6 | 2016 | 597 | 0.300 |
Why?
|
Extracellular Space | 3 | 2000 | 132 | 0.300 |
Why?
|
Self Report | 5 | 2018 | 756 | 0.290 |
Why?
|
Sex Factors | 6 | 2017 | 2139 | 0.290 |
Why?
|
Canada | 2 | 2021 | 429 | 0.290 |
Why?
|
Dietary Proteins | 5 | 2015 | 241 | 0.290 |
Why?
|
Placebos | 4 | 2013 | 437 | 0.280 |
Why?
|
Bromides | 2 | 2000 | 4 | 0.280 |
Why?
|
Double-Blind Method | 5 | 2013 | 2588 | 0.280 |
Why?
|
Cohort Studies | 8 | 2022 | 9244 | 0.270 |
Why?
|
Puberty | 2 | 2023 | 104 | 0.270 |
Why?
|
Diet Surveys | 2 | 2016 | 117 | 0.270 |
Why?
|
Hepatitis C | 2 | 2021 | 524 | 0.250 |
Why?
|
Plethysmography | 3 | 2012 | 31 | 0.240 |
Why?
|
Proteins | 6 | 2018 | 1963 | 0.240 |
Why?
|
Urine | 3 | 2012 | 143 | 0.240 |
Why?
|
Sexually Transmitted Diseases, Bacterial | 1 | 2003 | 3 | 0.240 |
Why?
|
Calibration | 3 | 2022 | 337 | 0.240 |
Why?
|
Life Style | 2 | 2022 | 612 | 0.240 |
Why?
|
School Health Services | 2 | 2016 | 109 | 0.230 |
Why?
|
Surveys and Questionnaires | 4 | 2021 | 5687 | 0.230 |
Why?
|
Transients and Migrants | 1 | 2003 | 27 | 0.230 |
Why?
|
Infant, Premature | 5 | 2012 | 787 | 0.230 |
Why?
|
Dietary Carbohydrates | 3 | 2020 | 134 | 0.230 |
Why?
|
Mammography | 1 | 2009 | 1010 | 0.220 |
Why?
|
Drinking | 1 | 2022 | 54 | 0.220 |
Why?
|
Breast | 2 | 2009 | 1344 | 0.220 |
Why?
|
Motor Activity | 5 | 2014 | 693 | 0.220 |
Why?
|
Membrane Proteins | 1 | 2013 | 2819 | 0.220 |
Why?
|
Health Services | 1 | 2023 | 105 | 0.210 |
Why?
|
Birth Weight | 4 | 2018 | 374 | 0.210 |
Why?
|
Pregnancy | 15 | 2022 | 7573 | 0.210 |
Why?
|
Hypocotyl | 2 | 2012 | 5 | 0.210 |
Why?
|
Pregnancy Trimesters | 2 | 2018 | 36 | 0.210 |
Why?
|
Heart Failure, Systolic | 1 | 2022 | 32 | 0.210 |
Why?
|
Endometrial Neoplasms | 1 | 2011 | 1341 | 0.210 |
Why?
|
Poverty | 2 | 2016 | 471 | 0.200 |
Why?
|
Aged | 20 | 2022 | 70117 | 0.200 |
Why?
|
Malnutrition | 2 | 2021 | 218 | 0.200 |
Why?
|
Lasers | 1 | 2022 | 198 | 0.200 |
Why?
|
Sexual Behavior | 1 | 2023 | 310 | 0.190 |
Why?
|
Urban Population | 4 | 2014 | 269 | 0.190 |
Why?
|
Body Fluid Compartments | 2 | 2018 | 21 | 0.190 |
Why?
|
Eating | 2 | 2017 | 421 | 0.190 |
Why?
|
Residence Characteristics | 2 | 2014 | 348 | 0.190 |
Why?
|
Regression Analysis | 6 | 2016 | 1546 | 0.190 |
Why?
|
Income | 1 | 2021 | 222 | 0.190 |
Why?
|
Plasma Volume | 1 | 2000 | 17 | 0.190 |
Why?
|
Pediatric Obesity | 2 | 2016 | 364 | 0.190 |
Why?
|
Accelerometry | 3 | 2018 | 63 | 0.180 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 1225 | 0.180 |
Why?
|
Health Resources | 1 | 2021 | 168 | 0.180 |
Why?
|
Women's Health | 2 | 2012 | 205 | 0.180 |
Why?
|
Longitudinal Studies | 7 | 2022 | 1945 | 0.180 |
Why?
|
Breeding | 1 | 1999 | 29 | 0.180 |
Why?
|
Water Supply | 1 | 2019 | 24 | 0.180 |
Why?
|
Nutritive Value | 2 | 2012 | 96 | 0.180 |
Why?
|
Carbohydrates | 1 | 2019 | 68 | 0.180 |
Why?
|
International Agencies | 1 | 2019 | 107 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 1999 | 60 | 0.180 |
Why?
|
Minerals | 2 | 1998 | 71 | 0.170 |
Why?
|
Survivors | 2 | 2015 | 1031 | 0.170 |
Why?
|
Sheep | 1 | 1999 | 258 | 0.170 |
Why?
|
Age Factors | 5 | 2018 | 5377 | 0.170 |
Why?
|
Literature, Modern | 1 | 2018 | 8 | 0.170 |
Why?
|
Cost-Benefit Analysis | 1 | 2023 | 945 | 0.170 |
Why?
|
Twins, Dizygotic | 1 | 2018 | 49 | 0.170 |
Why?
|
Ovariectomy | 1 | 2000 | 330 | 0.170 |
Why?
|
Hepacivirus | 1 | 2021 | 397 | 0.160 |
Why?
|
Weight Gain | 7 | 2022 | 464 | 0.160 |
Why?
|
Texas | 4 | 2014 | 6311 | 0.160 |
Why?
|
Insulin | 3 | 2018 | 1454 | 0.160 |
Why?
|
Linear Models | 6 | 2016 | 1085 | 0.160 |
Why?
|
Body Height | 2 | 2018 | 231 | 0.160 |
Why?
|
Phantoms, Imaging | 1 | 2004 | 1271 | 0.160 |
Why?
|
Hospitals | 1 | 2021 | 485 | 0.160 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 2195 | 0.160 |
Why?
|
Aged, 80 and over | 6 | 2022 | 29902 | 0.150 |
Why?
|
Potassium, Dietary | 1 | 2017 | 12 | 0.150 |
Why?
|
Social Class | 2 | 2022 | 310 | 0.150 |
Why?
|
Sodium, Dietary | 1 | 2017 | 34 | 0.150 |
Why?
|
Fetal Development | 1 | 2018 | 120 | 0.150 |
Why?
|
Mass Screening | 2 | 2018 | 1509 | 0.150 |
Why?
|
Cholesterol | 3 | 1995 | 658 | 0.150 |
Why?
|
Health Education | 3 | 2009 | 309 | 0.150 |
Why?
|
Skinfold Thickness | 2 | 2015 | 39 | 0.150 |
Why?
|
Reproduction | 3 | 2023 | 253 | 0.140 |
Why?
|
Sugars | 1 | 2016 | 15 | 0.140 |
Why?
|
Caloric Restriction | 1 | 2017 | 88 | 0.140 |
Why?
|
Heart Failure | 2 | 2022 | 2516 | 0.140 |
Why?
|
Photography | 1 | 2017 | 139 | 0.140 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1999 | 630 | 0.140 |
Why?
|
Carbon Dioxide | 11 | 1994 | 313 | 0.140 |
Why?
|
Dietary Sucrose | 1 | 2016 | 42 | 0.140 |
Why?
|
Biological Availability | 2 | 2011 | 214 | 0.140 |
Why?
|
Food | 3 | 2017 | 146 | 0.140 |
Why?
|
Databases, Factual | 2 | 2022 | 2218 | 0.140 |
Why?
|
Aging | 2 | 2022 | 1582 | 0.140 |
Why?
|
Chromatography, Ion Exchange | 2 | 2000 | 82 | 0.140 |
Why?
|
History, 20th Century | 1 | 2018 | 574 | 0.140 |
Why?
|
United States | 5 | 2023 | 15433 | 0.140 |
Why?
|
Seasons | 2 | 2013 | 340 | 0.140 |
Why?
|
Nitrogen | 2 | 2015 | 162 | 0.140 |
Why?
|
Calorimetry, Indirect | 4 | 2021 | 60 | 0.140 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 35 | 0.140 |
Why?
|
Soybean Proteins | 2 | 2011 | 20 | 0.130 |
Why?
|
Sri Lanka | 1 | 2015 | 8 | 0.130 |
Why?
|
Salvage Therapy | 1 | 2004 | 2054 | 0.130 |
Why?
|
Caregivers | 1 | 2021 | 677 | 0.130 |
Why?
|
Child Health Services | 1 | 2016 | 82 | 0.130 |
Why?
|
Risk Factors | 6 | 2018 | 17523 | 0.130 |
Why?
|
Analysis of Variance | 6 | 2004 | 2307 | 0.120 |
Why?
|
Healthy Volunteers | 1 | 2015 | 187 | 0.120 |
Why?
|
Recommended Dietary Allowances | 1 | 2014 | 24 | 0.120 |
Why?
|
Prevalence | 3 | 2018 | 3260 | 0.120 |
Why?
|
Delivery of Health Care | 1 | 2021 | 860 | 0.120 |
Why?
|
Pandemics | 1 | 2023 | 1559 | 0.120 |
Why?
|
Adaptation, Physiological | 2 | 2015 | 360 | 0.120 |
Why?
|
New Zealand | 1 | 2013 | 60 | 0.120 |
Why?
|
Founder Effect | 1 | 2013 | 42 | 0.120 |
Why?
|
Bariatric Surgery | 1 | 2015 | 107 | 0.120 |
Why?
|
British Columbia | 2 | 2023 | 24 | 0.120 |
Why?
|
Mutation | 1 | 2013 | 15179 | 0.110 |
Why?
|
Heart Rate | 3 | 2014 | 737 | 0.110 |
Why?
|
Gases | 1 | 2012 | 36 | 0.110 |
Why?
|
Cats | 1 | 2012 | 166 | 0.110 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1171 | 0.110 |
Why?
|
Markov Chains | 1 | 2013 | 175 | 0.110 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 56 | 0.110 |
Why?
|
Obesity, Morbid | 1 | 2015 | 224 | 0.110 |
Why?
|
Hypercholesterolemia | 1 | 1995 | 259 | 0.110 |
Why?
|
Catalysis | 1 | 2012 | 250 | 0.110 |
Why?
|
Platinum | 1 | 2012 | 138 | 0.100 |
Why?
|
Models, Statistical | 2 | 2018 | 1171 | 0.100 |
Why?
|
Infant Food | 5 | 2007 | 89 | 0.100 |
Why?
|
Renal Replacement Therapy | 1 | 2013 | 135 | 0.100 |
Why?
|
Equol | 1 | 2011 | 4 | 0.100 |
Why?
|
Zinc | 1 | 2012 | 188 | 0.100 |
Why?
|
Retrospective Studies | 6 | 2023 | 37905 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 10035 | 0.100 |
Why?
|
Breast Neoplasms | 3 | 2011 | 15694 | 0.100 |
Why?
|
Tritium | 1 | 1991 | 200 | 0.100 |
Why?
|
Physical Fitness | 2 | 2009 | 122 | 0.100 |
Why?
|
Lactation | 4 | 1997 | 210 | 0.090 |
Why?
|
Thiamine | 1 | 2009 | 11 | 0.090 |
Why?
|
Electric Conductivity | 4 | 2002 | 94 | 0.090 |
Why?
|
Riboflavin | 1 | 2009 | 26 | 0.090 |
Why?
|
Animals | 11 | 2022 | 59536 | 0.090 |
Why?
|
Vitamin B 12 | 1 | 2009 | 73 | 0.090 |
Why?
|
Endometrium | 1 | 2013 | 470 | 0.090 |
Why?
|
Follicle Stimulating Hormone | 1 | 2009 | 241 | 0.080 |
Why?
|
Gestational Age | 4 | 2018 | 1069 | 0.080 |
Why?
|
Carbon Isotopes | 5 | 1996 | 333 | 0.080 |
Why?
|
Sex Characteristics | 2 | 2022 | 417 | 0.080 |
Why?
|
Treatment Failure | 1 | 2012 | 1391 | 0.080 |
Why?
|
Time Factors | 4 | 2013 | 12926 | 0.080 |
Why?
|
Oxygen | 2 | 1999 | 754 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2016 | 14889 | 0.080 |
Why?
|
Lactose | 2 | 2005 | 63 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2018 | 32848 | 0.080 |
Why?
|
Phenotype | 2 | 2023 | 6295 | 0.080 |
Why?
|
Urban Health Services | 1 | 2007 | 37 | 0.080 |
Why?
|
Prospective Studies | 7 | 2021 | 12873 | 0.080 |
Why?
|
Vitamin D | 1 | 2009 | 261 | 0.070 |
Why?
|
Risk | 1 | 2012 | 1972 | 0.070 |
Why?
|
Guanidines | 1 | 1987 | 60 | 0.070 |
Why?
|
Mathematics | 7 | 2003 | 136 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 5767 | 0.070 |
Why?
|
Bias | 2 | 2015 | 205 | 0.070 |
Why?
|
Blood Chemical Analysis | 1 | 1987 | 118 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2012 | 598 | 0.070 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2006 | 26 | 0.070 |
Why?
|
Gastric Emptying | 1 | 2006 | 94 | 0.070 |
Why?
|
Electroacupuncture | 1 | 2006 | 35 | 0.070 |
Why?
|
Ultrasonography | 1 | 2013 | 1863 | 0.070 |
Why?
|
Reference Values | 3 | 2018 | 1099 | 0.070 |
Why?
|
Saliva | 1 | 1987 | 231 | 0.070 |
Why?
|
Body Fluids | 1 | 1987 | 125 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2015 | 4298 | 0.070 |
Why?
|
Carbon | 2 | 1985 | 149 | 0.070 |
Why?
|
HIV Antibodies | 1 | 2006 | 102 | 0.070 |
Why?
|
Cognition | 1 | 2012 | 968 | 0.070 |
Why?
|
Homosexuality, Male | 1 | 2005 | 71 | 0.070 |
Why?
|
Electric Impedance | 4 | 2001 | 100 | 0.070 |
Why?
|
Lactase | 1 | 2005 | 38 | 0.060 |
Why?
|
Syphilis | 1 | 2005 | 61 | 0.060 |
Why?
|
Health Behavior | 1 | 2009 | 603 | 0.060 |
Why?
|
Indians, North American | 2 | 1997 | 87 | 0.060 |
Why?
|
Incidence | 2 | 2012 | 5673 | 0.060 |
Why?
|
Thoracotomy | 1 | 2006 | 220 | 0.060 |
Why?
|
Bicarbonates | 6 | 1991 | 130 | 0.060 |
Why?
|
Leptin | 3 | 2015 | 295 | 0.060 |
Why?
|
Femur Neck | 1 | 2004 | 23 | 0.060 |
Why?
|
Radiodermatitis | 1 | 2004 | 75 | 0.060 |
Why?
|
Postpartum Period | 3 | 2018 | 259 | 0.060 |
Why?
|
Hip Joint | 1 | 2004 | 54 | 0.060 |
Why?
|
San Francisco | 1 | 2003 | 19 | 0.060 |
Why?
|
Interrupted Time Series Analysis | 1 | 2023 | 30 | 0.060 |
Why?
|
RNA, Viral | 1 | 2006 | 671 | 0.060 |
Why?
|
Femur | 1 | 2004 | 158 | 0.060 |
Why?
|
Actigraphy | 2 | 2014 | 54 | 0.060 |
Why?
|
Swine | 3 | 1993 | 1541 | 0.060 |
Why?
|
Calcium | 1 | 2009 | 1537 | 0.060 |
Why?
|
Humidity | 1 | 2022 | 29 | 0.060 |
Why?
|
Disease Outbreaks | 1 | 2005 | 415 | 0.060 |
Why?
|
Calorimetry | 3 | 1994 | 62 | 0.060 |
Why?
|
Thinness | 1 | 2003 | 82 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 2004 | 245 | 0.050 |
Why?
|
Research Design | 2 | 2022 | 1544 | 0.050 |
Why?
|
Spine | 1 | 2004 | 293 | 0.050 |
Why?
|
Disease Progression | 1 | 2013 | 6682 | 0.050 |
Why?
|
Sierra Leone | 1 | 2021 | 28 | 0.050 |
Why?
|
Prognosis | 3 | 2015 | 21713 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2014 | 2326 | 0.050 |
Why?
|
Oxygen Consumption | 4 | 2010 | 401 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 4938 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2022 | 139 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2007 | 1209 | 0.050 |
Why?
|
HIV-1 | 1 | 2006 | 653 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 7702 | 0.050 |
Why?
|
Pain, Postoperative | 1 | 2006 | 610 | 0.050 |
Why?
|
Mammals | 1 | 2022 | 361 | 0.050 |
Why?
|
Biomarkers | 3 | 2017 | 5047 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 1 | 2000 | 124 | 0.050 |
Why?
|
Prostate-Specific Antigen | 1 | 2004 | 993 | 0.050 |
Why?
|
Overnutrition | 1 | 2019 | 15 | 0.050 |
Why?
|
Health Personnel | 1 | 2005 | 625 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2014 | 3022 | 0.050 |
Why?
|
Electron Transport Complex IV | 1 | 1999 | 57 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 5539 | 0.040 |
Why?
|
Sexual Behavior, Animal | 1 | 1999 | 65 | 0.040 |
Why?
|
Animal Feed | 1 | 1999 | 81 | 0.040 |
Why?
|
False Negative Reactions | 1 | 1999 | 275 | 0.040 |
Why?
|
Prostatectomy | 1 | 2004 | 962 | 0.040 |
Why?
|
Growth | 1 | 1999 | 117 | 0.040 |
Why?
|
Dietary Fats | 2 | 2017 | 339 | 0.040 |
Why?
|
Neoplasms | 2 | 2015 | 15193 | 0.040 |
Why?
|
False Positive Reactions | 1 | 1999 | 355 | 0.040 |
Why?
|
Kinetics | 6 | 1995 | 2049 | 0.040 |
Why?
|
Software | 2 | 2004 | 1321 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 1081 | 0.040 |
Why?
|
Carbohydrate Metabolism | 1 | 2018 | 74 | 0.040 |
Why?
|
Breath Tests | 7 | 1991 | 177 | 0.040 |
Why?
|
Risk Assessment | 1 | 2011 | 6869 | 0.040 |
Why?
|
Failure to Thrive | 1 | 2018 | 91 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 1999 | 660 | 0.040 |
Why?
|
Body Weights and Measures | 1 | 2017 | 52 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2022 | 1270 | 0.040 |
Why?
|
Hepatitis C Antibodies | 1 | 2018 | 41 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2018 | 129 | 0.040 |
Why?
|
Hunger | 1 | 2017 | 47 | 0.040 |
Why?
|
Physical Examination | 1 | 1999 | 299 | 0.040 |
Why?
|
Surgical Flaps | 1 | 2004 | 927 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2022 | 1021 | 0.040 |
Why?
|
Chronic Disease | 2 | 2017 | 1819 | 0.040 |
Why?
|
Statistics as Topic | 2 | 2012 | 445 | 0.040 |
Why?
|
Waist Circumference | 1 | 2017 | 92 | 0.040 |
Why?
|
Medical Records | 2 | 2012 | 415 | 0.040 |
Why?
|
Time | 1 | 2017 | 178 | 0.040 |
Why?
|
Mammaplasty | 1 | 2004 | 780 | 0.040 |
Why?
|
Torso | 1 | 2017 | 73 | 0.040 |
Why?
|
Lysine | 2 | 1991 | 422 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2023 | 945 | 0.030 |
Why?
|
Body Size | 1 | 2016 | 70 | 0.030 |
Why?
|
Acceleration | 2 | 2012 | 32 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 4971 | 0.030 |
Why?
|
Fructose | 1 | 2016 | 72 | 0.030 |
Why?
|
Boston | 1 | 2015 | 108 | 0.030 |
Why?
|
Longevity | 1 | 2017 | 154 | 0.030 |
Why?
|
Peptide YY | 1 | 2015 | 21 | 0.030 |
Why?
|
Absorption | 1 | 1995 | 81 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2017 | 423 | 0.030 |
Why?
|
Mothers | 1 | 2018 | 410 | 0.030 |
Why?
|
Ergometry | 1 | 1994 | 5 | 0.030 |
Why?
|
Gastrointestinal Hormones | 1 | 2015 | 26 | 0.030 |
Why?
|
Intestinal Absorption | 5 | 2005 | 211 | 0.030 |
Why?
|
Blood Glucose | 1 | 1999 | 1244 | 0.030 |
Why?
|
Pilot Projects | 2 | 2015 | 2803 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 643 | 0.030 |
Why?
|
Adipokines | 1 | 2015 | 96 | 0.030 |
Why?
|
Maintenance Chemotherapy | 1 | 2015 | 202 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2015 | 169 | 0.030 |
Why?
|
Cholesterol, HDL | 2 | 2012 | 341 | 0.030 |
Why?
|
Physical Exertion | 2 | 2010 | 113 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 78 | 0.030 |
Why?
|
Monitoring, Ambulatory | 1 | 2014 | 63 | 0.030 |
Why?
|
Estrogens, Non-Steroidal | 1 | 1994 | 44 | 0.030 |
Why?
|
Lipids | 1 | 2017 | 644 | 0.030 |
Why?
|
Erythrocytes | 1 | 1995 | 339 | 0.030 |
Why?
|
HIV Infections | 1 | 2006 | 2134 | 0.030 |
Why?
|
Potassium | 2 | 2007 | 329 | 0.030 |
Why?
|
Triglycerides | 2 | 2012 | 603 | 0.030 |
Why?
|
Selection, Genetic | 1 | 1993 | 189 | 0.030 |
Why?
|
Lactation Disorders | 1 | 1992 | 8 | 0.030 |
Why?
|
Glycemic Index | 1 | 2012 | 29 | 0.030 |
Why?
|
Rats | 2 | 2000 | 6086 | 0.030 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2012 | 65 | 0.030 |
Why?
|
Anticholesteremic Agents | 1 | 1995 | 256 | 0.030 |
Why?
|
Chemistry | 1 | 1991 | 99 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 1991 | 137 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2012 | 388 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 460 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 1992 | 295 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2015 | 773 | 0.020 |
Why?
|
Anions | 1 | 1989 | 39 | 0.020 |
Why?
|
Swine, Miniature | 1 | 1989 | 67 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 2594 | 0.020 |
Why?
|
Wakefulness | 1 | 2010 | 150 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 3569 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2015 | 1271 | 0.020 |
Why?
|
Nephrectomy | 1 | 2014 | 779 | 0.020 |
Why?
|
Metabolic Syndrome | 1 | 2012 | 353 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2012 | 6100 | 0.020 |
Why?
|
Equipment Design | 2 | 2006 | 1204 | 0.020 |
Why?
|
Administration, Oral | 3 | 2006 | 1544 | 0.020 |
Why?
|
Flour | 1 | 2007 | 7 | 0.020 |
Why?
|
Microchemistry | 1 | 1987 | 11 | 0.020 |
Why?
|
Guanidine | 1 | 1987 | 12 | 0.020 |
Why?
|
Oxygen Radioisotopes | 1 | 1987 | 6 | 0.020 |
Why?
|
Physical Endurance | 1 | 2007 | 58 | 0.020 |
Why?
|
Zea mays | 1 | 2007 | 46 | 0.020 |
Why?
|
Evaluation Studies as Topic | 2 | 1984 | 418 | 0.020 |
Why?
|
Food, Fortified | 1 | 2007 | 95 | 0.020 |
Why?
|
Muscle Strength | 1 | 2007 | 104 | 0.020 |
Why?
|
Bottle Feeding | 1 | 2006 | 36 | 0.020 |
Why?
|
Glucans | 1 | 1986 | 18 | 0.020 |
Why?
|
Dextropropoxyphene | 1 | 2006 | 7 | 0.020 |
Why?
|
HIV Seroprevalence | 1 | 2006 | 11 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2006 | 204 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2012 | 731 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2006 | 32 | 0.020 |
Why?
|
Spectrophotometry, Infrared | 1 | 1985 | 33 | 0.020 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2006 | 59 | 0.020 |
Why?
|
Malawi | 1 | 2007 | 378 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 1985 | 128 | 0.020 |
Why?
|
Infant Formula | 1 | 2006 | 91 | 0.020 |
Why?
|
California | 1 | 2006 | 208 | 0.020 |
Why?
|
Fatty Acids, Volatile | 1 | 1985 | 52 | 0.020 |
Why?
|
Comorbidity | 1 | 2012 | 2352 | 0.020 |
Why?
|
Narcotics | 1 | 2006 | 123 | 0.020 |
Why?
|
Aminopyrine | 1 | 1985 | 5 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1989 | 1338 | 0.020 |
Why?
|
Lactose Intolerance | 1 | 2005 | 11 | 0.020 |
Why?
|
Acetaminophen | 1 | 2006 | 116 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 4988 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2006 | 306 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2005 | 75 | 0.020 |
Why?
|
Digestion | 1 | 2005 | 55 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2006 | 126 | 0.020 |
Why?
|
Registries | 1 | 2012 | 2170 | 0.020 |
Why?
|
Morphine | 1 | 2006 | 308 | 0.020 |
Why?
|
Intestine, Small | 2 | 2005 | 499 | 0.020 |
Why?
|
Methods | 1 | 2003 | 189 | 0.020 |
Why?
|
Perfusion | 1 | 2005 | 293 | 0.010 |
Why?
|
Edible Grain | 1 | 1983 | 54 | 0.010 |
Why?
|
Bone and Bones | 1 | 2007 | 619 | 0.010 |
Why?
|
Feces | 2 | 1983 | 770 | 0.010 |
Why?
|
Glucose | 2 | 1986 | 1248 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 665 | 0.010 |
Why?
|
Pain Measurement | 1 | 2006 | 953 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8865 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 10001 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2006 | 831 | 0.010 |
Why?
|
Paracoccus denitrificans | 1 | 1999 | 1 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 2422 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 2231 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12221 | 0.010 |
Why?
|
Skin | 1 | 2004 | 1259 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 783 | 0.010 |
Why?
|
Mastectomy | 1 | 2004 | 1534 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2004 | 3842 | 0.010 |
Why?
|
Child Development | 1 | 1997 | 255 | 0.010 |
Why?
|
Rest | 1 | 1994 | 71 | 0.010 |
Why?
|
Sodium Bicarbonate | 2 | 1985 | 59 | 0.010 |
Why?
|
Leucine | 1 | 1996 | 352 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 1994 | 54 | 0.010 |
Why?
|
Plant Preparations | 1 | 1994 | 36 | 0.010 |
Why?
|
Weaning | 1 | 1993 | 45 | 0.010 |
Why?
|
Exercise Test | 1 | 1994 | 312 | 0.010 |
Why?
|
Milk | 1 | 1994 | 120 | 0.010 |
Why?
|
Oxidation-Reduction | 2 | 1986 | 717 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 14289 | 0.010 |
Why?
|
Body Constitution | 1 | 1992 | 35 | 0.010 |
Why?
|
Mexico | 1 | 1992 | 259 | 0.010 |
Why?
|
Respiration | 2 | 1984 | 447 | 0.010 |
Why?
|
Estrogens | 1 | 1994 | 751 | 0.010 |
Why?
|
Radioisotope Dilution Technique | 1 | 1988 | 46 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5319 | 0.010 |
Why?
|
Electromagnetic Phenomena | 1 | 1986 | 18 | 0.000 |
Why?
|
Oligosaccharides | 1 | 1986 | 110 | 0.000 |
Why?
|
Half-Life | 1 | 1986 | 259 | 0.000 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1985 | 41 | 0.000 |
Why?
|
Acetates | 1 | 1985 | 105 | 0.000 |
Why?
|
Genotype | 1 | 1993 | 4109 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1984 | 191 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1986 | 931 | 0.000 |
Why?
|
Nutrition Disorders | 1 | 1984 | 57 | 0.000 |
Why?
|
Rabbits | 1 | 1985 | 957 | 0.000 |
Why?
|
Random Allocation | 1 | 1985 | 703 | 0.000 |
Why?
|
Sodium | 1 | 1985 | 353 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2006 | 11538 | 0.000 |
Why?
|
Rectum | 1 | 1985 | 467 | 0.000 |
Why?
|
Colon | 1 | 1983 | 670 | 0.000 |
Why?
|
Liver | 1 | 1985 | 2961 | 0.000 |
Why?
|